Search - tctmd.com

Displaying 621 - 640 of 1355

Sort: Relevancy | Date

Presentation TVT 2019

Adverse Clinical Outcomes Among Patients Undergoing Both PCI and TAVR: A Multicenter Analysis

Presenter: Arnav Kumar

June 13, 2019

Presentation TVT 2019

Transseptal Mitral Valve Replacement With a New Supra-Annular Valve in a Beating Human Cadaver Heart Biosimulator

Presenter: Yanping Cheng

June 13, 2019

Presentation TVT 2019

Clinical Determinants of Survival Among Patients Undergoing Transcatheter Mitral Valve Repair

Presenter: Matthew Miller

June 13, 2019

Presentation TVT 2019

Value of 3D Printing in Paravalvular Leaks Closure

Presenter: Vlad Ciobotaru

June 13, 2019

Presentation TVT 2019

Increased Mitral Valve Tenting Is Associated With Better Outcomes With Carillon Indirect Annuloplasty, Not Worse

Presenter: Steven Goldberg

June 13, 2019

Presentation TVT 2019

Nurse-Led Sedation for TAVR

Presenter: Bria Kneller

June 12, 2019

Presentation TVT 2019

Low-Risk Approval: Who Isn’t a Candidate for TAVR?

Presenter: Tsuyoshi Kaneko

June 12, 2019

Presentation TVT 2019

Plenary Lecture: Are There Still Imaging Challenges for TAVR?

Presenter: Jonathon Leipsic

June 12, 2019

News Conference News TVT 2017

Merits of Minimalist TAVR: Patient Satisfaction and a Better Bottom Line

Michael O'Riordan

June 20, 2017

News Conference News TVT 2017

Valve Leaflet Thrombosis: Treat It or Leave It Be?

Shelley Wood

June 19, 2017

News Conference News TVT 2017

Lagging Behind: Guidelines Can’t Keep Up With Growing TAVR Evidence Base

Michael O'Riordan

June 17, 2017

News Conference News TVT 2017

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

Shelley Wood

June 16, 2017

Presentation TVT 2017

Will the Heart Team Survive the Modern Era of Minimalist TAVR?

Presenter: Martin B. Leon, Hendrik Treede, Wilson Y. Szeto

June 16, 2017

Presentation TVT 2017

A Surgeons Viewpoint on SAVR vs TAVR Bioprosthetic Valve Durability

Presenter: Martin B. Leon, Hendrik Treede

June 16, 2017

Presentation TVT 2017

Hemodynamic Trends on Serial Echocardiograms After TAVR: Comprehensive 5-Year Analyses From the PARTNER 1 Trials

Presenter: Martin B. Leon, Hendrik Treede, Philippe Pibarot

June 16, 2017

Presentation TVT 2017

The Latest in TAVR Adjunctive Pharmacotherapy: The Case for Routine vs Selective Anticoagulant Therapy

Presenter: Martin B. Leon, Hendrik Treede, George D. Dangas

June 16, 2017

Presentation TVT 2017

An Imaging Perspective of Leaflet Thickening on MDCT: Lessons Learned and Next Steps

Presenter: Martin B. Leon, Hendrik Treede, Philipp Blanke

June 16, 2017

Presentation TVT 2017

Subclinical Leaflet Thrombosis in Surgical and Transcatheter Bioprosthetic Aortic Valves Cautionary Findings and Clinical Implications

Presenter: Martin B. Leon, Hendrik Treede, Raj Makkar

June 16, 2017

News Conference News TVT 2017

Volume Underload? More TAVRs Done, the Better the Operator Outcomes, Yet Many Patients Go Untreated

Michael O'Riordan

June 16, 2017

Presentation TVT 2017

Is the Current Practice of Watchful Waiting in Severe AS a Viable Strategy in the Future?

Presenter: David J. Cohen, Jeffrey J. Popma, Robert O. Bonow

June 16, 2017

Advertisement

Adverse Clinical Outcomes Among Patients Undergoing Both PCI and TAVR: A Multicenter Analysis

Transseptal Mitral Valve Replacement With a New Supra-Annular Valve in a Beating Human Cadaver Heart Biosimulator

Clinical Determinants of Survival Among Patients Undergoing Transcatheter Mitral Valve Repair

Value of 3D Printing in Paravalvular Leaks Closure

Increased Mitral Valve Tenting Is Associated With Better Outcomes With Carillon Indirect Annuloplasty, Not Worse

Nurse-Led Sedation for TAVR

Low-Risk Approval: Who Isn’t a Candidate for TAVR?

Plenary Lecture: Are There Still Imaging Challenges for TAVR?

Merits of Minimalist TAVR: Patient Satisfaction and a Better Bottom Line

Valve Leaflet Thrombosis: Treat It or Leave It Be?

Lagging Behind: Guidelines Can’t Keep Up With Growing TAVR Evidence Base

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

Will the Heart Team Survive the Modern Era of Minimalist TAVR?

A Surgeons Viewpoint on SAVR vs TAVR Bioprosthetic Valve Durability

Hemodynamic Trends on Serial Echocardiograms After TAVR: Comprehensive 5-Year Analyses From the PARTNER 1 Trials

The Latest in TAVR Adjunctive Pharmacotherapy: The Case for Routine vs Selective Anticoagulant Therapy

An Imaging Perspective of Leaflet Thickening on MDCT: Lessons Learned and Next Steps

Subclinical Leaflet Thrombosis in Surgical and Transcatheter Bioprosthetic Aortic Valves Cautionary Findings and Clinical Implications

Volume Underload? More TAVRs Done, the Better the Operator Outcomes, Yet Many Patients Go Untreated

Is the Current Practice of Watchful Waiting in Severe AS a Viable Strategy in the Future?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content